Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Bollineni RC"'
Autor:
Giannakopoulou E; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lehander M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Virding Culleton S; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Yang W; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Li Y; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Karpanen T; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Genomics Group, Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway., Yoshizato T; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Rustad EH; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Nielsen MM; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Bollineni RC; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tran TT; Department of Immunology, Oslo University Hospital, Oslo, Norway., Delic-Sarac M; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Gjerdingen TJ; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Douvlataniotis K; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Laos M; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ali M; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hillen A; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Mazzi S; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Chin DWL; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Mehta A; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway., Holm JS; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Bentzen AK; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Bill M; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Griffioen M; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Gedde-Dahl T; Hematology Department, Section for Stem Cell Transplantation, Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine, Oslo, Norway., Lehmann S; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Jacobsen SEW; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden. sten.eirik.jacobsen@ki.se.; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. sten.eirik.jacobsen@ki.se.; Karolinska University Hospital, Stockholm, Sweden. sten.eirik.jacobsen@ki.se.; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. sten.eirik.jacobsen@ki.se., Woll PS; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden. petter.woll@ki.se., Olweus J; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. johanna.olweus@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. johanna.olweus@medisin.uio.no.
Publikováno v:
Nature cancer [Nat Cancer] 2023 Oct; Vol. 4 (10), pp. 1474-1490. Date of Electronic Publication: 2023 Oct 02.
Autor:
Foldvari Z; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway., Knetter C; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway., Yang W; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway., Gjerdingen TJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway., Bollineni RC; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway., Tran TT; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway., Lund-Johansen F; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway., Kolstad A; Department of Oncology, Oslo University Hospital Radiumhospitalet, Oslo, Norway., Drousch K; Institute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Klopfleisch R; Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany., Leisegang M; Institute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. matthias.leisegang@charite.de.; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL, USA. matthias.leisegang@charite.de.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. matthias.leisegang@charite.de., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. johanna.olweus@medisin.uio.no.; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway. johanna.olweus@medisin.uio.no.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2023 Aug 22; Vol. 8 (1), pp. 126. Date of Electronic Publication: 2023 Aug 22.
Autor:
Meyer S; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Blaas I; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Bollineni RC; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Delic-Sarac M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Tran TT; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Knetter C; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Dai KZ; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Madssen TS; Department of Circulation and Medical Imaging, NTNU, 7030 Trondheim, Norway., Vaage JT; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Gustavsen A; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Yang W; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Nissen-Meyer LSH; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Douvlataniotis K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Laos M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway; Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, 50411 Tartu, Estonia., Nielsen MM; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Thiede B; Department of Biosciences, University of Oslo, 0371 Oslo, Norway., Søraas A; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway; ImmunoLingo Convergence Center, University of Oslo, 0372 Oslo, Norway., Rustad EH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway. Electronic address: ehrustad@gmail.com., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway. Electronic address: johanna.olweus@medisin.uio.no.
Publikováno v:
Cell reports [Cell Rep] 2023 Jan 31; Vol. 42 (1), pp. 111995. Date of Electronic Publication: 2023 Jan 09.
Autor:
Bollineni RC; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway., Tran TT; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway. Electronic address: fridtjol@gmail.com., Olweus J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. Electronic address: johanna.olweus@medisin.uio.no.
Publikováno v:
Current opinion in immunology [Curr Opin Immunol] 2022 Apr; Vol. 75, pp. 102172. Date of Electronic Publication: 2022 Mar 10.
Autor:
Ali M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Giannakopoulou E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Li Y; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lehander M; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Virding Culleton S; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Yang W; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Knetter C; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Odabasi MC; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany., Bollineni RC; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yang X; Parker Institute for Cancer Immunotherapy, Howard Hughes Medical Institute, Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Foldvari Z; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Böschen ML; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Taraldsrud E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Strønen E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Toebes M; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hillen A; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Mazzi S; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Janssen GMC; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Kolstad A; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital Radiumhospitalet, Oslo, Norway., Tjønnfjord GE; Department of Haematology, Oslo University Hospital and KG Jebsen Center for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lie BA; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway., Griffioen M; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Lehmann S; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden., Osnes LT; Department of Immunology, Oslo University Hospital, Oslo, Norway., Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway., Garcia KC; Parker Institute for Cancer Immunotherapy, Howard Hughes Medical Institute, Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Schumacher TN; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, the Netherlands., van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands., Leisegang M; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany.; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL, USA.; German Cancer Consortium, partner site Berlin, Berlin, Germany.; German Cancer Research Center, Heidelberg, Germany., Jacobsen SEW; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden.; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Woll P; Department of Medicine, Huddinge Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. johanna.olweus@medisin.uio.no.; K.G. Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. johanna.olweus@medisin.uio.no.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2022 Apr; Vol. 40 (4), pp. 488-498. Date of Electronic Publication: 2021 Dec 06.
Autor:
Tran TT; Department of Biosciences, University of Oslo, Norway. bernd.thiede@ibv.uio.no., Bollineni RC; Department of Biosciences, University of Oslo, Norway. bernd.thiede@ibv.uio.no., Koehler CJ; Department of Biosciences, University of Oslo, Norway. bernd.thiede@ibv.uio.no., Thiede B; Department of Biosciences, University of Oslo, Norway. bernd.thiede@ibv.uio.no.
Publikováno v:
The Analyst [Analyst] 2018 Sep 21; Vol. 143 (18), pp. 4359-4365. Date of Electronic Publication: 2018 Aug 16.
Autor:
Bollineni RC; Department of Biosciences, University of Oslo, Oslo, Norway., Koehler CJ; Department of Biosciences, University of Oslo, Oslo, Norway., Gislefoss RE; Cancer Registry of Norway, Institute of Populationbased Cancer Research, Oslo, Norway., Anonsen JH; Department of Biosciences, University of Oslo, Oslo, Norway., Thiede B; Department of Biosciences, University of Oslo, Oslo, Norway. bernd.thiede@ibv.uio.no.
Publikováno v:
Scientific reports [Sci Rep] 2018 Jun 22; Vol. 8 (1), pp. 9771. Date of Electronic Publication: 2018 Jun 22.
Autor:
Bollineni RC; Department of Biosciences, University of Oslo, Oslo, Norway., Koehler CJ; Department of Biosciences, University of Oslo, Oslo, Norway., Gislefoss RE; Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway., Anonsen JH; Department of Biosciences, University of Oslo, Oslo, Norway., Thiede B; Department of Biosciences, University of Oslo, Oslo, Norway. bernd.thiede@ibv.uio.no.
Publikováno v:
Scientific reports [Sci Rep] 2018 Feb 01; Vol. 8 (1), pp. 2117. Date of Electronic Publication: 2018 Feb 01.
Autor:
Tran TT; Department of Biosciences, University of Oslo , Oslo 0316, Norway., Bollineni RC; Department of Biosciences, University of Oslo , Oslo 0316, Norway., Strozynski M; Department of Biosciences, University of Oslo , Oslo 0316, Norway., Koehler CJ; Department of Biosciences, University of Oslo , Oslo 0316, Norway., Thiede B; Department of Biosciences, University of Oslo , Oslo 0316, Norway.
Publikováno v:
Journal of proteome research [J Proteome Res] 2017 Jul 07; Vol. 16 (7), pp. 2571-2578. Date of Electronic Publication: 2017 May 25.
Autor:
Koehler CJ; Department of Biosciences, University of Oslo, Oslo, Norway., Bollineni RC; Department of Biosciences, University of Oslo, Oslo, Norway., Thiede B; Department of Biosciences, University of Oslo, Oslo, Norway.
Publikováno v:
Rapid communications in mass spectrometry : RCM [Rapid Commun Mass Spectrom] 2017 Jan 30; Vol. 31 (2), pp. 227-233.